Skip to main content

and
  1. No Access

    Article

    ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study

    One of the major challenges in prostate cancer (PCa) treatment is distinguishing insignificant PCa from those forms that need active treatment. We evaluated the impact of PSA isoforms on risk stratification in...

    I Heidegger, H Klocker, R Pichler, A Pircher in Prostate Cancer and Prostatic Diseases (2017)

  2. Article

    Open Access

    EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205

    Expression of epithelial cell adhesion molecule (EpCAM) is deregulated in epithelial malignancies. Beside its role in cell adhesion, EpCAM acts as signalling molecule with tumour-promoting functions. Thus, EpC...

    P Massoner, T Thomm, B Mack, G Untergasser, A Martowicz in British Journal of Cancer (2014)

  3. No Access

    Article

    [-2]proPSA is an early marker for prostate cancer aggressiveness

    The aim of the study was to evaluate the correlation between preoperative [-2]proPSA, the Gleason Score (GS) and the risk of non-organ-confined (NOC) disease in patients undergoing radical prostatectomy (RP).

    I Heidegger, H Klocker, E Steiner, V Skradski in Prostate Cancer and Prostatic Diseases (2014)

  4. Article

    Open Access

    Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer

    The TMPRSS2-ERG gene fusion resulting in ERG overexpression has been found in around 50% of prostate cancers (PCa) and is a very early event in tumorigenesis. Most studies have reported on selected surgical cohor...

    G Schaefer, J-M Mosquera, R Ramoner, K Park in Prostate Cancer and Prostatic Diseases (2013)

  5. Article

    Open Access

    Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer

    Insulin-like growth factor (IGF) and insulin (INS) proteins regulate key cellular functions through a complex interacting multi-component molecular network, known as the IGF/INS axis. We describe how dynamic a...

    P Massoner, M Ladurner-Rennau, I E Eder, H Klocker in British Journal of Cancer (2010)

  6. No Access

    Article

    Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer

    Background: The type IV collagenases/gelatinases matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) play an important role in cancer invasion and metastasis. In the present study, we measured the expression of ...

    L Zhang, J Shi, J Feng, H Klocker, C Lee, J Zhang in Prostate Cancer and Prostatic Diseases (2004)

  7. Article

    Open Access

    Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

    Interactions between polypeptide growth factors and the androgen receptor (AR) are important for regulation of cellular events in carcinoma of the prostate. Basic fibroblast growth factor (bFGF), the prototype...

    M V Cronauer, C Nessler-Menardi, H Klocker, K Maly, A Hobisch in British Journal of Cancer (2000)

  8. Article

    Open Access

    Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

    Advanced prostate cancer is treated by androgen ablation and/or androgen receptor (AR) antagonists. In order to investigate the mechanisms relevant to the development of therapy-resistant tumours, we establish...

    Z Culig, J Hoffmann, M Erdel, I E Eder, A Hobisch, A Hittmair in British Journal of Cancer (1999)

  9. No Access

    Article

    Interleukin 1β mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

    Proliferative and secretory responses in androgen-sensitive prostate cancer LNCaP cells are regulated by steroid and peptide hormones and by differentiation-promoting substances. In the present study, we evalu...

    Z Culig, A Hobisch, M Herold, A Hittmair, M Thurnher, IE Eder in British Journal of Cancer (1998)

  10. No Access

    Article

    Amphiregulin is expressed in primary cultures of prostate myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue

    The effect and expression of amphiregulin, a growth factor of the EGF-system was investigated in prostate primary cell cultures and in human prostate tissue. Amphiregulin increases proliferation in primary cul...

    N Tørring, BS Sørensen, ST Bösch, H Klocker in Prostate Cancer and Prostatic Diseases (1998)

  11. No Access

    Article

    Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas

    We previously detected elevated transforming growth factor beta-1 (TGF-beta1) serum levels in patients with invasive bladder carcinomas. In this study, we therefore investigated whether elevated serum levels c...

    IE Eder, A Stenzl, A Hobisch, MV Cronauer, G Bartsch in British Journal of Cancer (1997)